Poorly differentiated eccrine carcinomas are associated with increased risk for poor outcomes - 14/12/22
Doi : 10.1016/j.jaad.2022.04.039
Neha Gupta, MPH a, b, Alexa Conomikes, BA a, Fadi Murad, MD, MPH a, Emily S. Ruiz, MD, MPH a, ⁎ 
a Department of Dermatology, Brigham and Women’s Hospital, Harvard Medical School, Boston, Massachusetts
b Case Western Reserve University School of Medicine, Cleveland, Ohio
∗Correspondence to: Emily S. Ruiz, MD, MPH, Assistant Professor of Dermatology, Department of Dermatology, Brigham and Women’s Hospital, Harvard Medical School, 1153 Centre Street, Suite 4J, Jamaica Plain, MA 02130Harvard Medical SchoolDepartment of DermatologyBrigham and Women’s Hospital1153 Centre Street, Suite 4JJamaica PlainMA02130
Key words : distant metastasis, disease-specific death, eccrine carcinoma, local recurrence, nodal metastasis
| Authors Gupta and Conomikes are cofirst authors. |
|
| Funding sources: None. |
|
| IRB approval status: Reviewed and approved by Mass General Brigham Human Research Committee Protocol: 2020P003634. |
© 2022
American Academy of Dermatology, Inc.. Publié par Elsevier Masson SAS. Tous droits réservés.
Vol 88 - N° 1
P. 210-212 - janvier 2023 Retour au numéro
Article précédent
- Greater rosacea severity correlates with greater adherence and improvement in a clinical study
- Patrick O. Perche, Rohan Singh, Madison K. Cook, Katherine A. Kelly, Esther A. Balogh, Irma Richardson, Steven R. Feldman
- Single-question parent-reported global atopic dermatitis severity: A valid instrument in children
- Jonathan I. Silverberg, Stephanie M. Rangel, Anjani Sheth, Alli Blumstein, Amy S. Paller
Bienvenue sur EM-consulte, la référence des professionnels de santé.
L’accès au texte intégral de cet article nécessite un abonnement.
Déjà abonné à cette revue ?